<?xml version="1.0" encoding="UTF-8"?>
<ref id="B313-molecules-26-00883">
 <label>313.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mali</surname>
    <given-names>A.V.</given-names>
   </name>
   <name>
    <surname>Padhye</surname>
    <given-names>S.B.</given-names>
   </name>
   <name>
    <surname>Anant</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Hegde</surname>
    <given-names>M.V.</given-names>
   </name>
   <name>
    <surname>Kadam</surname>
    <given-names>S.S.</given-names>
   </name>
  </person-group>
  <article-title>anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives</article-title>
  <source>Eur. J. Pharmacol.</source>
  <year>2019</year>
  <volume>852</volume>
  <fpage>107</fpage>
  <lpage>124</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ejphar.2019.02.022</pub-id>
  <?supplied-pmid 30771348?>
  <pub-id pub-id-type="pmid">30771348</pub-id>
 </element-citation>
</ref>
